web analytics

Welcome to Discuva

Discuva is a drug discovery company focused on the creation of Next Generation targeted antimicrobials against new emerging and drug-resistant bacterial pathogens.

From a study of 114 countries, the World Health Organisation has predicted a future where all current antibiotic drugs are ineffective. In this ‘post-antibiotic era’ a simple scratch or routine surgical procedure will be a potentially life-threatening event.

At Discuva, using ground-breaking new technologies, we are successfully developing completely new classes of antibiotics which we believe will play a major role in protecting society from the forthcoming threat promised by the emergence of drug-resistant bacteria.

Upcoming Events

Latest Tweets from @DiscuvaLtd

Discuva Ltd @DiscuvaLtd
RT @ASMnewsroom: Researchers discover novel, colistin resistance gene, mcr-3, in E. coli. - Study in @ASMicrobiology's @mbiojournal https:/…
Discuva Ltd @DiscuvaLtd
UTIs turn fatal with reckless #antibiotic use https://t.co/WPcgbLFOKD via @timesofindia
Discuva Ltd @DiscuvaLtd
'Exaggerations' threaten public trust in #science, says leading statistician https://t.co/p3GCFjx6oO